ORL.TO Allkem Limited (TSX) closed C$8.28 on 03 Mar 2026: Oversold bounce insight
ORL.TO stock finished the TSX session at C$8.28 on 03 Mar 2026, up 3.63% from yesterday’s close as buying emerged after a recent oversold run. The session closed with 19,462 shares traded, below the 50-day average of 43,906, suggesting a measured rebound rather than broad conviction. For traders using an oversold bounce strategy, today’s strength and a 50-day average of C$8.43 set a short-term resistance test. Meyka AI’s market tools flag a clear mean-reversion setup inside the Basic Materials sector, where the 3‑month sector gain is 21.85%, supporting demand-led recovery themes
ORL.TO stock: Market snapshot and price action
Allkem Limited (ORL.TO) closed at C$8.28, with a session range C$8.12–C$8.34 and a one-day gain of C$0.29 or 3.63%. Volume was 19,462 versus average volume 43,906, showing lighter trading on the bounce which often precedes follow-through if volume picks up
ORL.TO stock: Why this looks like an oversold bounce
The stock traded well below its 50-day mean in recent weeks and re-tested support near the YTD low before today’s rebound, fitting an oversold bounce pattern. Short-term volatility is modest with an ATR of C$0.22, so measured entries with tight stops match the strategy
ORL.TO stock: Fundamentals, valuation and Meyka AI grade
Allkem shows mixed fundamentals: EPS stands at -0.23 and reported a trailing PE of -36.16, while price-to-book is 1.13 and cash per share is C$1.29. Meyka AI rates ORL.TO with a score of 63.45 out of 100 (Grade: B, Suggestion: HOLD). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics and analyst consensus
ORL.TO stock: Catalysts and headline risks
Operational catalysts include ramp at Olaroz and progress at Cauchari that can lift near-term volumes and margins. Key risks are lithium price swings, Argentina policy and FX exposure; each can quickly reverse an oversold bounce into resumed selling
ORL.TO stock: Trading levels, targets and technicals
Near-term resistance lies at the 50-day average C$8.43 and the recent high C$9.30; support sits near C$7.06 (200-day mean) and the year low C$3.89. A conservative tactical target for an oversold bounce trade is C$10.50 (+26.74% from C$8.28), with a bullish scenario tied to Meyka AI’s model at C$16.33
ORL.TO stock: Sector context and liquidity
Allkem sits in Canada’s Basic Materials group where 3‑month performance is +21.85% and YTD +19.88%, supporting cyclical demand tailwinds. Liquidity is modest on TSX with average volume 43,906, so size positions to avoid market impact
Final Thoughts
Key takeaways: ORL.TO stock closed the TSX session at C$8.28 on 03 Mar 2026 with a 3.63% gain that matches a textbook oversold bounce. Volume was light at 19,462, so traders should watch for follow-through above the 50-day average C$8.43 before adding size. Fundamentals are mixed — EPS -0.23 and negative trailing PE highlight recent profit variability, while a low debt ratio and C$1.29 cash per share support balance sheet resilience. Meyka AI’s forecast model projects C$16.33 (monthly projection), implying +97.25% versus the current price, but that is model-based and not guaranteed. For oversold bounce tactics we recommend defined risk entries, a stop under recent support near C$7.00, and targets at C$10.50 (conservative) and C$16.33 (bullish model). Use the company site for primary releases and our Meyka AI pages for live signals and updates Allkem site Meyka stock page
FAQs
Is ORL.TO stock a buy after today’s bounce?
ORL.TO stock shows a tactical entry if price clears C$8.43 on increased volume. Use tight stops below C$7.00 and size positions for the short term. Confirm with fresh volume or catalysts before holding long term.
What are realistic price targets for ORL.TO stock?
For an oversold bounce, a near-term target is C$10.50 (+26.74%). Meyka AI’s model projects C$16.33, a bullish scenario. Forecasts are projections, not guarantees.
How do fundamentals affect ORL.TO stock risk?
ORL.TO stock has EPS -0.23 and a negative trailing PE, which raises earnings risk. Balance sheet metrics like cash per share C$1.29 and low debt help but cyclicality and commodity exposure remain material risks.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)